| ★ | Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026 | | 548 | Estados Unidos | |
| 6 | Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients | ATS 2026 | | 1.2K | Estados Unidos | 85 |
| 3 | La Universitat se suma al Dia Europeu de Dèficit d'Alfa-1 | Universitat de València @universitatvalencia | 481 | España | 86 |
| 5 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 86 |
| 15 | Ralinepag Cuts PAH Clinical Worsening Risk by 55%, With Vallerie McLaughlin, MD | ATS 2026 | | 290 | Estados Unidos | 84 |
| 19 | Aire limpio en casa: cómo proteger tu salud de toxinas invisibles 🍃🏠 | Como Me Nutro @comomenutro | 272 | España | 83 |
| 10 | Sotatercept May Improve Right Heart Function in #pulmonaryhypertension | | 232 | Estados Unidos | 85 |
| 12 | Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD | | 198 | Estados Unidos | 85 |
| 1 | Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results | | 156 | Estados Unidos | 96 |
| 14 | Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026 | | 117 | Estados Unidos | 84 |
| 13 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 85 |
| 9 | Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 85 |
| 7 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 85 |
| 2 | Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results | | 82 | Estados Unidos | 95 |
| 20 | ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More | HCPLive Expert Interviews | | 70 | Estados Unidos | 83 |
| 16 | Functional Air Trapping May Predict Pneumothorax After BLVR | | 56 | Estados Unidos | 84 |
| 8 | ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews | | 55 | Estados Unidos | 85 |
| 4 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 86 |
| 17 | Helping Patients Breathe Easier | Lynn Bingaman, CRNP at Geisinger | Geisinger @geisingerhealth | 45 | Estados Unidos | 84 |
| 11 | Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD | | 29 | Estados Unidos | 85 |
| 18 | APPs on the Front Lines of AATD Management | | 9 | Estados Unidos | 84 |